| mRNA |
MS-275 |
gCSI |
pan-cancer |
AAC |
0.0068 |
0.9 |
| mRNA |
NSC-87877 |
GDSC1000 |
pan-cancer |
AAC |
-0.0044 |
0.9 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0039 |
0.9 |
| mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
0.0066 |
0.9 |
| mRNA |
KIN001-102 |
GDSC1000 |
pan-cancer |
AAC |
0.0035 |
0.9 |
| mRNA |
GSK4112 |
CTRPv2 |
pan-cancer |
AAC |
-0.0044 |
0.9 |
| mRNA |
lenalidomide |
GDSC1000 |
pan-cancer |
AAC |
0.0041 |
0.9 |
| mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0039 |
0.9 |
| mRNA |
YK 4-279 |
GDSC1000 |
pan-cancer |
AAC |
0.0042 |
0.9 |
| mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.9 |